
BREAKING NEWS California rocked by multiple earthquakes along fault line poised for 'The Big One'
The US Geological Survey (USGS) detected the seismic activity along the San Andreas Fault, which spans 800 miles from Cape Mendocino in the north to the Salton Sea in the south.
Scientists have warned that this fault is overdue for 'The Big One,' which would be a magnitude 7.8 or higher.
While Friday's earthquakes ranged from a 2.5 to 2.9 magnitude, scientists determined that a 2.5 magnitude or higher can be felt and may cause injuries and damages.
No injuries or damages have been reported as of yet.
Experts are 'fairly confident that there could be a pretty large earthquake at some point in the next 30 years,' Angie Lux, project scientist for Earthquake Early Warning at the Berkeley Seismology Lab, previously told DailyMail.com.
The 'Big One' would cause roughly 1,800 deaths, 50,000 injuries and $200 billion in damages, according to the Great California Shakeout.
This is a developing story... More updates to come.
USGS detected the first quake, a 2.9 magnitude, Thursday afternoon, northeast of San Francisco.
This tremor was located on Calaveras Fault, a major branch of the San Andreas Fault system.
The following earthquakes hit Friday morning, one along another branch of the major fault and another directly on it.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
.jpg%3Ftrim%3D0%2C0%2C0%2C0%26width%3D1200%26height%3D800%26crop%3D1200%3A800&w=3840&q=100)

The Independent
an hour ago
- The Independent
Man dies after contracting brain-eating amoeba in tourist hotspot
A Missouri resident has died from a rare Naegleria fowleri infection, commonly known as a "brain-eating amoeba", after water skiing in the Lake of the Ozarks. The individual passed away on 19 August at a hospital in the St. Louis area, with preliminary information indicating exposure occurred shortly before falling ill. Naegleria fowleri is a microscopic amoeba typically found in warm freshwater, and infections are extremely rare in the US, with fewer than 10 cases reported annually. The amoeba enters the body through the nose, travelling to the brain, and infections are almost always fatal, though they cannot spread between people or by swallowing water. This incident follows other recent cases in the US, including the death of a child in South Carolina and a 71-year-old woman in Texas who contracted the amoeba from tap water.


Times
an hour ago
- Times
If aliens find Earth, they'll probably come from this direction
Humans dream of finding life on Mars — but could our fascination with this neighbouring planet broadcast our existence to aliens who live much further away? A review of the most powerful signals that humans have sent into space has shed light on how extraterrestrials might find us. The study analysed the logs of Nasa's Deep Space Network (DSN), an array of radio dishes in California, Spain and Australia that communicate with the agency's far-flung spacecraft. It concluded that the bulk of humanity's most powerful, persistent signals into the cosmos had been directed not at distant stars but at machines orbiting or roving the red planet. Mars does not block these signals, so they continue to stream out into space, along paths that align with it and Earth.


The Sun
2 hours ago
- The Sun
Fat jabs reduce the risk of cancer by 17% in overweight and obese people – except one, warn scientists
WEIGHT loss jabs could lower the risk of cancer, scientists say. They found GLP-1s like Ozempic and Mounjaro reduced the overall chances of the disease by 17 per cent in overweight and obese patients. 2 The decreased risk was strongest for ovarian, womb and certain brain tumours. But people taking the jabs were still less likely to develop other types, including pancreatic, bladder and breast cancer, than those not on the medication. It's another breakthrough for the 'miracle' injections, which have already been shown to tackle type 2 diabetes, heart disease, stroke and possibly dementia. Author Dr Jiang Bian, from the Indiana University School of Medicine, said: 'GLP-1s are widely prescribed for glycemic control in type 2 diabetes and have recently gained popularity for weight management. 'We found they were associated with a reduced overall risk of cancer. 'Even modest changes in cancer risk could have substantial public health implications.' However, researchers also found that taking so-called 'fat jabs', which mimic a hormone to make users feel full, might be associated with an increased risk of kidney cancer, especially among users under 65. 'Further research is needed to clarify this potential risk,' Dr Bian said. The study, published in the journal JAMA Oncology, couldn't conclude whether the change in cancer risk over eight years was due to the jabs themselves or drug-induced weight loss. But scientists reckon that lower body fat, improved insulin sensitivity and reduced inflammation could be to thank. Don't fall for fake Mounjaro scams to save money on fat jab - it put me in a 'coma' & I'm still suffering, says Aisleyne Horgan-Wallace In trials, semaglutide (sold as Ozempic and Wegovy) helped users lose around 15 per cent of their body weight in 68 weeks, while those on tirzepatide (Mounjaro) shed up to 21 per cent. Dr Stephen Lawrence, associate clinical professor at the University of Warwick, who was not involved in the study, said: 'These drugs not only help shed pounds and lower blood sugar, but might add a modest bonus by being slightly associated with reducing overall cancer risk, especially for specific women's cancers. 'With millions now eligible for GLP-1 therapy, even small shifts in risk matter at scale. 'These medicines remain widely safe, with a reassuring cancer profile and only a whisper of concern about an associated increase in kidney cancer.' Are you eligible for fat jabs on the NHS? By Isabel Shaw, Health Reporter TO be eligible for weight loss injections on the NHS, you typically need a high BMI (body mass index) and a number of weight-related health conditions. A BMI of 40 or more is usually required, or a BMI of 37.5 or more for certain ethnic groups. For people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean ethnic backgrounds, a lower BMI of 37.5 or higher may be considered due to increased health risks at lower BMI levels within these groups. Additionally, you must have at least three or four of the following conditions: Type 2 diabetes High blood pressure Heart disease Obstructive sleep apnoea Abnormal blood fats These injections are generally provided with a structured weight management programme that includes lifestyle support. If you're looking to access weight loss injections on the NHS, discuss your options with your GP. The jabs are also available privately, though at a considerable cost. On average, they will set users back around £150 to £200 a month.